India has officially surpassed Japan to become the fourth-largest economy in the world, with a GDP of over USD 4 trillion, as per NITI Aayog CEO BVR Subrahmanyam. According to Rajiv Nath, Forum...
Divi's Laboratories Limited has entered into a long-term manufacturing and supply agreement with a leading global pharmaceuticals company to manufacture and supply advanced intermediates that...
Lupin pharmaceutical announced that it has entered into a license and supply agreement with SteinCares for the commercialization of biosimilar ranibizumab throughout all of Latin America...
Lincoln Pharmaceuticals Limited, one of India's leading healthcare companies has reported a standalone net profit of Rs. 82.44 crore for the FY25 ended March 2025 as against net profit of Rs. 93.37 crore FY24.
Alembic Pharmaceuticals has received final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Amlodipine and Atorvastatin Tablets USP...
Zydus Lifesciences is developing a new semaglutide formulation for diabetes and obesity, two rapidly growing chronic conditions that are becoming increasingly debilitating. Rather than requiring patients to...
According to Anish Bafna, CEO and Managing Director of Healthium Medtech, sustainability is growing a vital factor in global healthcare finding, especially across the US and Europe.
-min.png)
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has advised its members to freshly apply again to the Production Linked Incentive.
Indian Pharma Expands as Global Players Cut Insulin FocusIndian pharmaceutical firms like Eris Lifesciences, Lupin, Mankind, and Wockhardt are quickly growing their footprint in India's insulin market, long monopolized by the likes of Novo...
Eris Lifesciences Limited, a leading Indian branded formulations manufacturing company, today announced its earnings for the fourth quarter and full year FY25.
, CDSCO.jpg)
